GTENW: the cash flow

Cash Flow Overview

Unit: Dollar

Positive Cash Flow Breakdown

Negative Cash Flow Breakdown

Cash Flow

2025-09-30

2025-06-30

Net income

1,843,616

-1,791,913

Allocated expense for warrant issuance cost

1,062

101,971

Interest reinvested in the trust account

3,707,618

2,306,234

Loss from change in fair value of public warrant liabilities

1,524,900

3,767,400

Prepaid assets

-92,260

540,253

Accrued expenses, formation and offering costs

133,354

468,087

Net cash used in operating activities

-112,426

-300,942

Cash deposited in trust account

358,800,000

Net cash used in investing activities

-358,800,000

Proceeds from sale of units in initial public offering

358,800,000

Proceeds from sale of private placement shares to sponsor

2,250,000

Deferred offering costs

461,412

Payment of accrued offering costs

746,871

Payment of underwriters' discounts and commissions

250,000

Proceeds from notes payable - related party

59,000

Repayment of notes payable - related party

231,901

Net cash provided by financing activities

359,418,816

Net change in cash

-112,426

317,874

Cash and cash equivalents at beginning of period

2,774

Cash and cash equivalents at end of period

208,222

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow Overview

Unit: Dollar

Positive Cash Flow Breakdown

Negative Cash Flow Breakdown

Cash Flow

2025-09-30

2025-06-30

Net income

1,843,616

-1,791,913

Allocated expense for warrant issuance cost

1,062

101,971

Interest reinvested in the trust account

3,707,618

2,306,234

Loss from change in fair value of public warrant liabilities

1,524,900

3,767,400

Prepaid assets

-92,260

540,253

Accrued expenses, formation and offering costs

133,354

468,087

Net cash used in operating activities

-112,426

-300,942

Cash deposited in trust account

358,800,000

Net cash used in investing activities

-358,800,000

Proceeds from sale of units in initial public offering

358,800,000

Proceeds from sale of private placement shares to sponsor

2,250,000

Deferred offering costs

461,412

Payment of accrued offering costs

746,871

Payment of underwriters' discounts and commissions

250,000

Proceeds from notes payable - related party

59,000

Repayment of notes payable - related party

231,901

Net cash provided by financing activities

359,418,816

Net change in cash

-112,426

317,874

Cash and cash equivalents at beginning of period

2,774

Cash and cash equivalents at end of period

208,222

Time Plot

Show the time plot by selecting a row from the table.